Page Banner

United States Department of Agriculture

Agricultural Research Service

Research Project: Processing Technologies to Prevent Weight Gain and Obesity Related Metabolic Diseases

Location: Healthy Processed Foods Research

Title: Gel coating of edible Brasenia schreberi leaves lowers plasma cholesterol in hamsters (abstract)

Authors
item Kim, Hyunsook -
item Wang, Qian -
item Shoemaker, Charles -
item Zhong, Fang -
item Bartley, Glenn
item Yokoyama, Wallace

Submitted to: Meeting Abstract
Publication Type: Abstract Only
Publication Acceptance Date: March 28, 2013
Publication Date: May 30, 2013
Citation: Kim, H., Wang, Q., Shoemaker, C.F., Zhong, F., Bartley, G.E., Yokoyama, W.H. 2013. Gel coating of edible Brasenia schreberi leaves lowers plasma cholesterol in hamsters (abstract). 10th International Conference of Food Science and Technology, Wuxi, China, May 29-31, 2013.

Technical Abstract: The young leaves of B. schreberi are coated with gelatinous water-insoluble mucilage. This mucilage is a polysaccharide composed of galactose, mannose, fucose and other monosaccharides. Since some carbohydrate gels are hypocholesterolemic, we evaluated the cholesterol lowering properties in male hamsters fed hypercholesterolemic diets containing either 2% gel coat from B. schreberi (GEL), or 1% cholestyramine (CA), or 5% hydroxypropyl methylcellulose (HPMC) and compared them to 5% microcrystalline cellulose (control) for 3 weeks. We found that plasma VLDL-, LDL-, and total-cholesterol concentrations were significantly lowered by GEL, CA, and HPMC compared to control. HDL-cholesterol concentration was lowered by CA and HPMC. Body weights were not changed by any treatment but abdominal adipose tissue weight from GEL fed animals was greater compared to the control group. Fecal lipid excretion was greater in the CA and HPMC than the control. Expression of hepatic CYP51 and CYP7A1 mRNA was up-regulated by CA, HPMC and GEL, indicating increased hepatic cholesterol and bile acid synthesis. Expression of LDLR mRNA was up-regulated by all treatments. These results suggest that modulation of hepatic expression of cholesterol and bile acid metabolism-regulated genes contributes to the cholesterol-lowering effects of GEL.

Last Modified: 4/17/2014
Footer Content Back to Top of Page